A few other states are planning or considering obesity drug restrictions in state fiscal year 2026 or 2027, and state interest in expanding coverage of obesity drugs is also waning according to this years survey, with states continuing to report cost as the key factor contributing to obesity drug coverage decisions
The finding that lipotoxicity alters incretin receptor expression is reminiscent of the decrease in insulin gene expression observed under similar conditions
Original price was: 2,500 .1,690 Current price is: 1,690
The most common issue is purity overstatement, where a supplier claims 99% purity but independent testing reveals the actual figure is closer to 88-94%
Lastly, a combination of exendin-4 and metformin has been shown to attenuate different forms of cancer at a more noticeable rate [94, 95]
For instance, low sensitivity and poor recovery of phosphate on conventional SST hardware were observed